PredictMe develops an AI platform that analyzes epigenetic markers to detect disease risk and calculate biological age through DNA methylation. Its commercial offering, PredictMe Delta, is a blood test that provides a biological-age metric and clinical decision support within 24 hours. The company’s AI model has been trained on data from 150,000 individuals and processes nearly 60 billion data points. PredictMe was founded by Professor Maria Lerm and Professor Mika Gustafsson from Linköping University. The startup has received research grants from the Knut and Alice Wallenberg Foundation and Vinnova and now completed a SEK 5 million seed round led by Linus Gunnarson. PredictMe plans to use the new capital to scale deployment and integrate its data-driven insights into standard clinical practice.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2026